Exploration génomique de l’agressivité des tumeurs neuroendocrines hypophysaires (PitNETs)
Nesrine Benanteur(Inserm), G. Assie(Centre National de la Recherche Scientifique), J. Bertherat(Hôpital Cochin), Mirella Hage(Université de Versailles Saint-Quentin-en-Yvelines), Chiara Villa(Centre National de la Recherche Scientifique), Franck Letourneur(Inserm), Julien Masliah‐Planchon(Physique des Cellules et Cancers), Fabio Bioletto(Department of Medical Sciences), M.F. Birtolo(Inserm), J.-F. Emile(Hôpital Ambroise-Paré), A. Jouinot(Centre National de la Recherche Scientifique), V. Gravrand(Inserm), Bertrand Baussart(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
|Nature Genetics|2015|375
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340
Pangenomic Classification of Pituitary Neuroendocrine Tumors
|Cancer Cell|2019|335